AdaptHealth Corp. (NASDAQ:AHCO) Stake Raised by Franklin Resources Inc.

Franklin Resources Inc. raised its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 20.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,601 shares of the company’s stock after acquiring an additional 11,037 shares during the quarter. Franklin Resources Inc.’s holdings in AdaptHealth were worth $737,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Canada Pension Plan Investment Board purchased a new position in AdaptHealth during the second quarter valued at approximately $58,000. Quarry LP boosted its stake in shares of AdaptHealth by 4,596.9% during the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after buying an additional 5,838 shares during the period. Quest Partners LLC grew its holdings in shares of AdaptHealth by 11,522.7% during the 2nd quarter. Quest Partners LLC now owns 10,228 shares of the company’s stock valued at $102,000 after acquiring an additional 10,140 shares in the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of AdaptHealth in the second quarter worth $113,000. Finally, Johnson Investment Counsel Inc. purchased a new stake in shares of AdaptHealth during the second quarter worth $115,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $9.53 on Monday. The firm has a market capitalization of $1.28 billion, a PE ratio of -5.78, a PEG ratio of 1.36 and a beta of 1.10. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth Corp. has a 1 year low of $6.46 and a 1 year high of $11.90. The firm’s fifty day simple moving average is $10.04 and its 200 day simple moving average is $10.41.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The business had revenue of $805.90 million during the quarter, compared to the consensus estimate of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.19 earnings per share. On average, sell-side analysts anticipate that AdaptHealth Corp. will post 0.88 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have commented on the company. Truist Financial lowered their target price on AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, November 15th. Robert W. Baird dropped their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a report on Wednesday, November 6th. UBS Group reduced their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Canaccord Genuity Group dropped their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Finally, Royal Bank of Canada reduced their price objective on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating for the company in a research note on Tuesday, November 19th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $11.67.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.